JP2011057615A - Salt compounded with lava powder - Google Patents
Salt compounded with lava powder Download PDFInfo
- Publication number
- JP2011057615A JP2011057615A JP2009209097A JP2009209097A JP2011057615A JP 2011057615 A JP2011057615 A JP 2011057615A JP 2009209097 A JP2009209097 A JP 2009209097A JP 2009209097 A JP2009209097 A JP 2009209097A JP 2011057615 A JP2011057615 A JP 2011057615A
- Authority
- JP
- Japan
- Prior art keywords
- lava
- lava powder
- powder
- salt
- fuji
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 68
- 150000003839 salts Chemical class 0.000 title claims abstract description 38
- 235000010724 Wisteria floribunda Nutrition 0.000 claims abstract description 13
- 239000002245 particle Substances 0.000 claims abstract description 6
- 238000010298 pulverizing process Methods 0.000 claims abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 235000013402 health food Nutrition 0.000 abstract description 2
- 235000002639 sodium chloride Nutrition 0.000 abstract 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000011780 sodium chloride Substances 0.000 abstract 2
- 238000013329 compounding Methods 0.000 abstract 1
- 239000011800 void material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- 239000011630 iodine Substances 0.000 description 8
- 229910052740 iodine Inorganic materials 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 210000003800 pharynx Anatomy 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 5
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000002324 mouth wash Substances 0.000 description 4
- 229940051866 mouthwash Drugs 0.000 description 4
- 239000012266 salt solution Substances 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 235000021110 pickles Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- -1 iron ions Chemical class 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
この発明は、風邪、アレルギー性鼻炎、喘息、咽喉頭炎等の種々の症状が出た際に、喉や口腔内又は咽腔内に噴霧等を行って、その症状を緩和させたり、前記各症状を予防する際に使用する溶岩パウダーを配合した塩に関するものである。 This invention, when various symptoms such as cold, allergic rhinitis, asthma, pharyngopharyngitis, etc., sprayed into the throat, oral cavity or pharynx, alleviate the symptoms, The present invention relates to a salt containing lava powder used to prevent symptoms.
従来の含嗽剤成分は、主としてアズノール製剤、アズレン製剤、臭化ドミフェン製剤、ポピドンヨード製剤によるものが周知である。
これらの製剤による含嗽効果は、弱いものであり、またその製剤の成分によって誤って衣服などに付くとシミを生じたり、ヨード成分独特の臭いと味がある。
さらに、甲状腺機能亢進等の疾患を持つ者には、使用は禁止されている。
Conventional gargle ingredients are well known mainly by an aznol formulation, an azulene formulation, a domifene bromide formulation and a popidone iodine formulation.
The moisturizing effect of these preparations is weak, and if the ingredients of the preparations are mistakenly attached to clothes or the like, they cause spots or have a unique smell and taste.
Furthermore, use is prohibited for persons with diseases such as hyperthyroidism.
また、含嗽剤としては、殺菌剤主薬製剤及び消炎剤主薬製剤があり、前者は、口腔内及び喉の殺菌・消毒・清浄、口臭の除去を目的とし、後者は、口腔内の洗浄、口腔・咽喉（またはのど）のはれの除去等を目的としている。
例えば、殺菌剤主薬製剤としては、塩化セチルピリジニウム主薬製剤、グルコン酸クロルヘキシジン主薬製剤、ポピドンヨード主薬製剤を挙げることができる。その例としては、パブロン（登録商標）うがい薬、ルゴール液、イソジン（登録商標）うがい薬、コルゲンコーワ（登録商標）うがい薬等がある。
消炎剤主薬製剤としては、水溶性アズレン主薬製剤を挙げることができる。
In addition, the gargle includes a bactericidal agent formulation and an anti-inflammatory agent agent formulation. The former is for the purpose of sterilizing / disinfecting / cleaning the mouth and throat, removing bad breath, and the latter is for cleaning the mouth, The purpose is to remove throat (or throat) swelling.
For example, the bactericide main agent preparation may include cetylpyridinium chloride main drug preparation, chlorhexidine gluconate main drug preparation, and popidone iodine main drug preparation. Examples include Pavlon (registered trademark) mouthwash, Lugol solution, Isodine (registered trademark) mouthwash, Korgen Kowa (registered trademark) mouthwash, and the like.
Examples of the anti-inflammatory agent active ingredient preparation include a water-soluble azulene active ingredient preparation.
含嗽剤の主薬となっている前記殺菌剤成分のポピドンヨードやクロルヘキシジンは、ヨード過敏症やショック症状などの副作用が報告されており、必要以上の使用を避けたり、アレルギーの有無等の確認が必要となることが考えられる。
また、下記特許文献１に記載の含嗽剤は、ヨウ素−シクロデキストリン包接化物を主成分とするアルコール溶媒からなるものであり、長期保存安定性に優れるものである。
特許文献２には塩化亜鉛の水溶液を主成分とする含嗽剤が提案されている。
Side effects such as iodine hypersensitivity and shock symptoms have been reported for the antibacterial ingredients popidone iodine and chlorhexidine, which are the main ingredients of gargle, and it is necessary to avoid excessive use and to check for allergies. It is possible to become.
Moreover, the gargle described in Patent Document 1 below is composed of an alcohol solvent containing an iodine-cyclodextrin inclusion product as a main component, and has excellent long-term storage stability.
Patent Document 2 proposes a gargle containing an aqueous solution of zinc chloride as a main component.
この発明の溶岩パウダーを配合した塩においては、上記従来の含嗽剤に存する問題点、例えばヨード成分を利用するものにあっては、衣服の汚れやその味や臭い等を排除すること、あるいは、副作用の全くないうがい薬を提供すること、また、含嗽効果が大きく且つ即効性のあるものを提供することがその課題である。
併せて、使用に際して、全く違和感がなく、すなわち薬品自体の味や臭い等のない、極めて清涼感に優れたものを提供することもその課題である。
さらに、この発明はうがい用のみならず、飲料その他各種の食品、健康食品等に好適に使用可能な溶岩パウダーを配合した塩を提供することをその目的とするものである。
In the salt containing the lava powder of the present invention, the problems existing in the conventional gargle, such as those using an iodine component, to eliminate the dirt of the clothes and its taste and smell, or The problem is to provide a mouthwash with no side effects and to provide a product with a large gargle effect and immediate effect.
At the same time, it is also an object to provide a product that has no sense of incongruity in use, that is, does not have the taste or smell of the medicine itself, and has a very refreshing feeling.
Furthermore, an object of the present invention is to provide a salt containing lava powder that can be suitably used not only for gargle but also for beverages and other various foods and health foods.
上記課題を解決するために、この発明の溶岩パウダーを配合した塩は、塩を主成分とし、これに溶岩パウダーを配合したことを特徴とするものである。 In order to solve the above-mentioned problems, a salt containing the lava powder of the present invention is characterized by containing a salt as a main component and lava powder.
この発明の溶岩パウダーを配合した塩は、前記塩１００重量％に対し、溶岩パウダーを１０〜２０重量％配合したことをも特徴とするものである。 The salt in which the lava powder of the present invention is blended is also characterized in that 10 to 20% by weight of lava powder is blended with respect to 100% by weight of the salt.
この発明の溶岩パウダーを配合した塩は、前記溶岩パウダーが、富士山系、特に富士五湖周辺で産出した溶岩のパウダーであることをも特徴とするものである。 The salt mixed with the lava powder of the present invention is also characterized in that the lava powder is lava powder produced in the Mt. Fuji series, particularly around the Fuji Five Lakes.
この発明の溶岩パウダーを配合した塩は、前記溶岩パウダーが、気泡率が３０％以上の溶岩を粉末化したものであって、該溶岩パウダーの９５％以上が粒子径１．０μｍ未満であることをも特徴とするものである。
このように、この発明において使用する溶岩パウダーは、富士山系、特に富士五湖周辺において産出する溶岩を粉砕して得たパウダーであることが望ましい。この富士山系、特に富士五湖周辺において産出する溶岩は、気泡率が３０％以上で遠赤外線の生成に優れた作用を発揮することが知られている。
また、前記溶岩パウダーとしては、見掛け比重１．９５ｇ／ｃｍ2の富士山系の溶岩を乾式粉砕した後、更に湿式粉砕処理を行い、溶岩パウダーの水分散液（溶岩パウダーの重量割合は２０重量％）を得た。この溶岩パウダーは、その９５％以上が粒子径１．０μｍ未満であり、数平均粒子径０．７μｍ程度であり、最大粒子径が２．５μｍであった。
In the salt containing the lava powder of the present invention, the lava powder is obtained by pulverizing lava having a bubble ratio of 30% or more, and 95% or more of the lava powder has a particle diameter of less than 1.0 μm. Is also a feature.
Thus, the lava powder used in the present invention is desirably a powder obtained by pulverizing lava produced in the Mt. Fuji system, particularly in the vicinity of Fuji Five Lakes. It is known that lava produced in the Mt. Fuji system, particularly around the Fuji Five Lakes, has an air bubble ratio of 30% or more and exhibits an excellent action in generating far-infrared rays.
In addition, as the lava powder, lava of Mt. Fuji having an apparent specific gravity of 1.95 g / cm 2 is dry-pulverized and further wet-pulverized to obtain an aqueous dispersion of lava powder (the lava powder has a weight ratio of 20% by weight). ) 95% or more of this lava powder had a particle size of less than 1.0 μm, a number average particle size of about 0.7 μm, and a maximum particle size of 2.5 μm.
この発明の溶岩パウダーを配合した塩においては、うがい用として水溶液で使用したばあにその含嗽効果（殺菌効果と消炎効果）が高く、その効き目が早いという大きな効果を挙げることができる。
またうがいの際に、ヨード製剤を使用していないために、ヨードによる衣服の汚れ、その味と臭いを排除できる。
また、溶岩パウダーを配合した塩の水溶液は、ほぼ無色無臭であり、ヨード製剤等を使用したものと異なり、違和感なく使用することができる。
この発明にあっては、この溶岩パウダーを配合した塩の水溶液でうがいしたり、噴霧器等を用いて、口腔、鼻腔、或は咽喉頭に噴霧して使用するのが最適であり、これにより細菌の除去、異物（感染源）の除去、炎症の沈静或は炎症の予防に効果を発揮し、治癒効果を向上させることができる。
これらの効果は、溶岩パウダーの殺菌効果等によるものと考えられる。以下のグラフに溶岩パウダーの各種細菌に対する殺菌等の効果を示す。
In the salt containing the lava powder of the present invention, there is a great effect that the gargle effect (bactericidal effect and anti-inflammatory effect) is high and the effect is fast when used in an aqueous solution for gargle.
In addition, since no iodine preparation is used during gargle, it is possible to eliminate the stains, taste and smell of clothes due to iodine.
In addition, an aqueous salt solution mixed with lava powder is almost colorless and odorless, and can be used without a sense of incompatibility, unlike those using iodine preparations.
In this invention, it is optimal to gargle with an aqueous salt solution containing this lava powder, or to spray the oral cavity, nasal cavity, or pharynx using a nebulizer or the like. It is effective in removing the foreign matter, removing foreign substances (infectious source), calming inflammation or preventing inflammation, and improving the healing effect.
These effects are considered to be due to the bactericidal effect of the lava powder. The following graph shows the effect of sterilization of various lava powders against various bacteria.
また、新型インフルエンザウイルス（Ｈ１Ｎ１）に対する富士山系の、特に富士五湖周辺において産出する溶岩の溶岩パウダーによる不活化試験結果によると、新型インフルエンザウイルス（Ｈ１Ｎ１）原液に対しては２０時間で、１００倍希に対しては直後より不活化効果を認めたという試験結果が、東邦大学医学部 感染制御学 小林 寅≡ 教授より出されている。 In addition, according to the inactivation test results of lava powder produced in the Mt. Fuji series, especially around the Fuji Five Lakes against the new influenza virus (H1N1), it is 100 times in 20 hours against the stock solution of the new influenza virus (H1N1). A test result that innocent effect was recognized for Nozomi immediately after noble was given by Professor Toshin University School of Medicine.
このような溶岩パウダーの殺菌作用については次のように考えることができる。
すなわち、活性酸素種の一つである過酸化水素がからだの中で作られ、それが微量金属元素（溶岩パウダー中に含まれる）、例えば鉄イオンやその錯体と反応すると、ヒドロキシラジカル（・ＯＨ）が生まれる。これは種々の物質を強く酸化する力を持っているので、これが細菌に働きかけるのではないかと思われる（金属は人体になぜ必要か、桜井 弘著 株式会社講談社発行）。
The bactericidal action of such lava powder can be considered as follows.
That is, hydrogen peroxide, which is one of the active oxygen species, is produced in the body, and when it reacts with trace metal elements (contained in lava powder) such as iron ions and their complexes, hydroxy radicals (.OH ) Is born. Since this has the ability to strongly oxidize various substances, it seems that this may act on bacteria (why metals are necessary for the human body, published by Hiroshi Sakurai, Kodansha Co., Ltd.).
以下、本発明の実施形態について説明する。
この発明に係る溶岩パウダーを配合した塩の要旨は、前記塩１００重量％に対し、溶岩パウダーを１０〜２０重量％配合したものであり、溶岩パウダーを配合した塩の水溶液を主成分としていることである。
したがってこの発明においては、その溶岩パウダーを配合した塩を家庭の水で薄めて使用することも、また予め精製水等で所定濃度まで希釈し溶岩パウダーを配合した塩の水溶液をそのまま、噴霧器（スプレー）等を使用して患部に噴射することもできる。
Hereinafter, embodiments of the present invention will be described.
The gist of the salt containing the lava powder according to the present invention is that 10 to 20% by weight of lava powder is added to 100% by weight of the salt, and the main component is an aqueous salt solution containing the lava powder. It is.
Therefore, in the present invention, the salt mixed with the lava powder can be used by diluting with home water, or the salt aqueous solution mixed with the lava powder can be diluted with purified water or the like to a predetermined concentration. ) Etc. can also be injected into the affected area.
上記溶岩パウダーを配合した塩の配合割合は、前記塩１００重量％に対し、溶岩パウダーを１０〜２０重量％配合することが望ましい。
溶岩パウダーが３重量％未満のときは良好な殺菌効果を得ることが難しく、また溶岩パウダーが２０重量％以上のときは塩の結晶との良好な化学結合の関係が解かれ、溶岩パウダーが粉っぽくなって塩中に混在するようになってしまう。
The mixing ratio of the salt containing the lava powder is desirably 10 to 20% by weight of lava powder with respect to 100% by weight of the salt.
When the lava powder is less than 3% by weight, it is difficult to obtain a good bactericidal effect. When the lava powder is more than 20% by weight, the relationship between the chemical bonds with the salt crystals is solved and the lava powder is powdered. It becomes so mixed that it becomes mixed in the salt.
噴霧器（スプレー）としては、各種の形態のものが既に存在しており、手動ポンプ式の噴霧器を使用し、喉に噴霧する場合或は鼻腔に噴霧する場合に適合するタイプのものを利用すればよい。
したがって使用者は、この本発明に係る溶岩パウダーを配合した塩の水溶液をこれら適宜タイプの噴霧器に充填して噴霧して使用するのである。
また、この発明に係る溶岩パウダーを配合した塩の水溶液が、胃内部に吸収されたとしても極めて微量のために、全く問題を生じる恐れはない。
勿論、使用に際して、この水溶液をそのまま口腔内に含み、うがいを行って、その後吐き出す形で使用することもできるが、噴霧した方が薬剤の無駄を省くことができ、且つ患部の奥の方まで良好に到達させることができる。
Various types of sprayers (sprays) already exist, and if you use a manual pump type sprayer and use a type that is suitable for spraying to the throat or spraying to the nasal cavity Good.
Therefore, the user fills and sprays an aqueous solution of a salt containing the lava powder according to the present invention in these appropriate types of sprayers.
Moreover, even if the aqueous salt solution blended with the lava powder according to the present invention is absorbed in the stomach, there is no possibility of causing any problems at all due to the extremely small amount.
Of course, in use, this aqueous solution can be included in the oral cavity as it is, gargle, and then used in the form of exhalation, but spraying can save the waste of the medicine and the depth of the affected area It can reach well.
次に、この発明においては、上記溶岩パウダーを配合した塩の水溶液に加えて、収斂材として、ホウ砂、ホウ酸、または明礬等を加えることができる。
収斂剤を加えるのは、その消炎効果を更に高めるためである。
Next, in the present invention, borax, boric acid, alum or the like can be added as an astringent in addition to the salt aqueous solution containing the lava powder.
The astringent is added to further enhance the anti-inflammatory effect.
次に、この発明に係る溶岩パウダーを配合した塩をうがい用溶液として使用し、その症状の改善状況を示す実例について説明する。 Next, the example which shows the improvement condition of the symptom using the salt which mix | blended the lava powder concerning this invention as a solution for gargle is demonstrated.
１）うがい用溶液
（状況）風邪の引き掛け時の喉の痛み、風邪罹患中の喉の痛み。
（本発明使用後状況）風邪の引き掛け時に、本発明に係る含嗽剤を１日適数回使用した。喉の痛みも、従来の風邪の際に比較すると弱く、罹患後も、継続使用することにより重症にならず、痰が膿性から漿液性に変化した。
従来の症状に比較すると、風邪の症状が格段に軽く治まった。
1) Gargle solution (situation) Sore throat when catching a cold, sore throat while suffering from a cold.
(Situation after use of the present invention) The gargle according to the present invention was used an appropriate number of times a day when catching a cold. The sore throat was also weaker than in the case of a conventional cold, and even after illness, it became less severe with continued use, and the sputum changed from purulent to serous.
Compared to conventional symptoms, the symptoms of colds were relieved lightly.
２）調味料
（状況）みそ汁に食塩に代えて使用
（本発明使用後状況）今までにない風味のおいしいみそ汁であった。
すなわち、溶岩パウダーのミネラル成分、特に含有塩素は消化を助け、また亜鉛は味覚に対する感覚を高める作用があり、塩分とともにみそ汁の風味となって現れたものと思われる。
したがって、他の煮物、焼き魚類、焼き肉類の調理に使用しても、その風味がより一層高まるものと考えられる。
また漬物類に使用した場合には、漬け床の臭いが緩和され、しかも一段と風味の優れた漬物類が得られた。
2) Seasoning (situation) It was used in place of salt in miso soup (situation after use of the present invention).
That is, the mineral component of lava powder, especially chlorine, helps digestion, and zinc has the effect of enhancing the sense of taste, which appears to be miso soup with salt.
Therefore, even if it uses for cooking of other boiled foods, grilled fish, and grilled meat, it is thought that the flavor increases further.
In addition, when used for pickles, the pickle floors were alleviated and the pickles were more excellent in flavor.
３）飲料
（状況）スポーツドリンク其の他の飲料に塩分に代えて使用
（本発明使用後状況）溶岩パウダー中のミネラルのうち、鉄やモリブデンなどは他のミネラルと協同してヘモグロビンの活躍を促進させ、酸素を体の隅々まで運び、筋肉中に取り入れることができるので、より大きな力を発揮させることができるとともに、だるさや疲れを緩和してスポーツ力を増大させることができる。
したがって、他の煮物、焼き魚類、焼き肉類の調理に使用しても、その風味がより一層たまるものと考えられる。
3) Beverages (situation) Sports drinks Other beverages used instead of salt (post-use situation) Among the minerals in lava powder, iron, molybdenum, etc. cooperate with other minerals to play an active role in hemoglobin Because it can be promoted, oxygen can be carried to every corner of the body and taken into the muscles, more power can be exerted, and the sport power can be increased by relieving dullness and fatigue.
Therefore, even if it uses for cooking of other boiled foods, grilled fish, and grilled meat, it is thought that the flavor accumulates further.
４）経口剤
（状況）食塩に代えて少量ずつ経口摂取
（本発明使用後状況）溶岩パウダー中のミネラルのうち、バナジウムや亜鉛、クロム、マンガンは協同してインシュリンの働きを活性化し、血糖値を正常にし、糖尿病の改善に役立つ。
また、溶岩パウダー中のカルシウムやカリ、マンガンは其の他のミネラルと協同して骨の形成に役立つので、骨太の健康な体を育成してくれることとなる。
また、ミネラルが不足すると、肌が荒れたり、毛が抜けやすくなったり、老化現象や糖尿病などの種々さまざまな病が進行するが、溶岩パウダーによって不足したミネラル分が補給され、健康が回復することになる。
4) Oral preparation (situation) Oral intake in small amounts instead of salt (situation after use of the present invention) Among the minerals in lava powder, vanadium, zinc, chromium and manganese cooperate to activate insulin, and blood sugar level Helps normalize and improve diabetes.
In addition, calcium, potash, and manganese in lava powder cooperate with other minerals to help form bones, so that a healthy body can be nurtured.
Also, when minerals are deficient, skin becomes rough, hair is easily removed, and various diseases such as aging and diabetes progress, but the lack of minerals is replenished by lava powder and health is restored. become.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009209097A JP2011057615A (en) | 2009-09-10 | 2009-09-10 | Salt compounded with lava powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009209097A JP2011057615A (en) | 2009-09-10 | 2009-09-10 | Salt compounded with lava powder |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012003715U Continuation JP3179673U (en) | 2012-06-20 | 2012-06-20 | Salt mass with lava powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2011057615A true JP2011057615A (en) | 2011-03-24 |
Family
ID=43945681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009209097A Pending JP2011057615A (en) | 2009-09-10 | 2009-09-10 | Salt compounded with lava powder |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2011057615A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013159593A (en) * | 2012-02-08 | 2013-08-19 | Yogan Kenkyusho:Kk | Method of detoxifying toxic substance and radioactive substance inside living body using lava powder and volcanic ash and method of improving polluted field |
| JP2015054848A (en) * | 2013-09-13 | 2015-03-23 | 株式会社トータルサポートサービス | Cosmetic substrate containing lava stone and production method thereof and cosmetics using the same |
| KR101918329B1 (en) | 2014-10-08 | 2018-11-14 | 현대자동차주식회사 | A low-nickel austenitic Casting Steel with Superior Tensile Strength and Resistance to Oxidation on High Temperature and EGR cooler system using the same |
-
2009
- 2009-09-10 JP JP2009209097A patent/JP2011057615A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013159593A (en) * | 2012-02-08 | 2013-08-19 | Yogan Kenkyusho:Kk | Method of detoxifying toxic substance and radioactive substance inside living body using lava powder and volcanic ash and method of improving polluted field |
| JP2015054848A (en) * | 2013-09-13 | 2015-03-23 | 株式会社トータルサポートサービス | Cosmetic substrate containing lava stone and production method thereof and cosmetics using the same |
| KR101918329B1 (en) | 2014-10-08 | 2018-11-14 | 현대자동차주식회사 | A low-nickel austenitic Casting Steel with Superior Tensile Strength and Resistance to Oxidation on High Temperature and EGR cooler system using the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104873432B (en) | Handguard type Washing free gel for disinfection and preparation method thereof | |
| KR20170040524A (en) | A method wipes containing the composition without the irritation on bamboo fabric | |
| JP2011057615A (en) | Salt compounded with lava powder | |
| KR101130691B1 (en) | Hand-disinfectant composition for anti-bacteria-increasing containing the extracts of natural material | |
| CN102845486A (en) | Herbal disinfectant | |
| CN102860324A (en) | Household cleaning and sterilizing agent | |
| CN105534818B (en) | A kind of catechin mouthwash and preparation method thereof | |
| JP3179673U (en) | Salt mass with lava powder | |
| JP2001131018A (en) | Functional composition | |
| WO2017068546A1 (en) | Composition for oral hygiene | |
| JP3522380B2 (en) | Bath composition | |
| US20020114851A1 (en) | Therapeutic mouthwash containing alkali metal hypohalite | |
| KR20170141870A (en) | Mouth and nose cleaning liquid comprising oxygen | |
| JP7175467B2 (en) | Antiviral agents and antiviral compositions against norovirus and its alternative viruses | |
| CN106962400A (en) | A kind of high-efficiency plant composition cleanser containing trivalent silver iron and preparation method thereof | |
| KR20220037887A (en) | High performance deodorization material using hydrogen peroxide and preparing method thereof | |
| JP2022082279A (en) | Preventive agent against infectious diseases | |
| KR20100057121A (en) | Cosmetic composition for deodorization | |
| CA2252670C (en) | Low ph acidic compositions | |
| JP7621599B2 (en) | Bath salts containing dolomite | |
| CN114099567B (en) | Sterilizing and deodorizing spray for shoes and socks and preparation method thereof | |
| US20160279037A1 (en) | Cosmetic compositions comprising micro-silver and methods of applying the same | |
| CN107184500A (en) | A kind of hand cleanser and preparation method | |
| JP3457395B2 (en) | Bath composition | |
| JP2024060626A (en) | Aqueous composition for external use, and composition for producing ozone water |